Brokers' take
Japfa Ltd | Buy (maintained) Dec 12 close: S$0.75 Target price: S$0.99 Maybank Kim Eng Research, Dec 12
Fuelled by the rebound in PT Japfa Tbk and animal protein other (APO) divisions, year-to-date FY18 has been far stronger than we expected. Upcoming Indonesian presidential elections, our forecast Indonesian rupiah appreciation and a softening in soybean meal should provide further tailwinds in coming quarters. Taking stock of various protein, dairy and commodity input prices, we raise FY18E/FY19E/FY20E core profit estimates by 23 per cent/9 per cent/9 per cent, and target price by 15 per cent to S$0.99.
Apart from usual average selling price swings, regulation change, raw material cost, disease and weather related risks inherent to agri businesses, the specific risks to our outlook lie in the consumer foods business posting higher than forecast losses, emerging Asia currency weakness versus USD and risk of illegal Chinese pork imports into Vietnam.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
JPMorgan promotes about 150 in Asia, EMEA to managing director
Brokers’ take: Analysts upgrade iFast’s rating on higher growth expectations
Stellantis misses forecasts with 12% revenue drop in Q1, sees stronger H2
L'Occitane's billionaire owner Geiger to take firm private in US$1.8 billion deal
Australian budget airline Bonza collapses, passengers stranded
HSBC CEO to retire; bank reports 1.7% lower Q1 profit of US$10.8 billion